Market revenue in 2022 | USD 1,736.2 million |
Market revenue in 2030 | USD 3,140.0 million |
Growth rate | 7.7% (CAGR from 2022 to 2030) |
Largest segment | Dermal fillers |
Fastest growing segment | Ophthalmic |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Dermal fillers was the largest segment with a revenue share of 52.57% in 2022. Horizon Databook has segmented the Europe hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
In Europe, the market is witnessing a shift from multiple-injection cycle products to single-injection for osteoarthritis treatment, owing to greater convenience provided by single-injection products.
It is also expected that due to higher relative cost-benefit provided by single-injection treatment, the threeinjection treatment segment will lose part of its share to single-injection treatments.
Moreover, less stringent regulatory framework for hyaluronic acid-based product approval is expected to drive the market in Europe. Osteoporosis affects more than 2.5 million women in both the UK and France every year.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hyaluronic acid market , including forecasts for subscribers. This continent databook contains high-level insights into Europe hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account